fosinopril has been researched along with fosinoprilat in 28 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (14.29) | 18.7374 |
1990's | 12 (42.86) | 18.2507 |
2000's | 7 (25.00) | 29.6817 |
2010's | 4 (14.29) | 24.3611 |
2020's | 1 (3.57) | 2.80 |
Authors | Studies |
---|---|
Auch-Schwelk, W; Bossaller, C; Claus, M; Fleck, E; Graf, K; Gräfe, M | 1 |
Duchin, KL; Frantz, M; Manning, J; Tu, JI; Waclawski, AP; Willard, DA | 1 |
Cushman, DW; Dzwonczyk, S; Fung, W; Grover, GJ; Sleph, PG; Tobias, D; Wang, P | 1 |
Abboa-Offei, B; Seymour, AA; Swerdel, JN | 1 |
Andersen, AR; Ibsen, H; Paulson, OB; Rasmussen, S; Strandgaard, S; Waldemar, G | 1 |
Brennan, J; Eckelman, WC; Stouffer, B; Tu, JI | 1 |
Cushman, DW; DeForrest, JM; Harvey, C; Petrillo, EW; Powell, JR; Rubin, B; Scalese, B; Waldron, TL | 1 |
Mackaness, GB | 1 |
Cohen, AI; Ivashkiv, E; Jemal, M; Ribick, M | 1 |
Alpaugh, WC; Stauber, KL; Swanson, BN; Weinstein, SH | 1 |
Baker, JR; Bigby, TD; Kylstra, TA | 1 |
Ford, NF; Hammett, JL; Lasseter, KC; Manning, J; Raymond, R; Van Harken, DR | 1 |
Duchin, KL; Gehr, TW; Grasela, DM; Sica, DA | 1 |
Casaretto, H; Hauswirth, O; Koppers, D; Lemke, P; Räcke, HF | 1 |
Delaney, C; Garland, WT; Kostis, JB; Liao, WC; Norton, J | 1 |
Chu, KM; Ding, PY; Hu, OY; Huang, CS; Hwang, GM | 1 |
Caspi, A; Greenbaum, R; Liao, WC; Mangold, B; Nouriel, H; O'Grady, P; Paz, R; Sclarovsky, S; Yee, KF; Zucchelli, P | 1 |
Jemal, M; Mulvana, DE | 1 |
Huang, M; Jemal, M; Mao, Y; Schuster, A; Whigan, D | 1 |
Burnett , JC; Chen, HH; Harty, GJ; Lainchbury, JG; Matsuda, Y | 1 |
Bartels, T; Betge, S; Dendorfer, A; Dominiak, P; Raasch, W | 1 |
Dimkovic, N; Ivanovic, D; Jancic, B; Malenovic, A; Medenica, M | 1 |
Ivanović, D; Janci, B; Malenović, A; Marković, S; Medenica, M | 1 |
Hu, L; Hu, Y; Huang, J; Li, G; Si, L; Sun, X; Xue, K | 1 |
Abu Hasan, Z'; Acharya, KR; Cozier, GE; Isaac, RE; Ismail, NM; Othman, H; Williams, H | 1 |
Acharya, KR; Cashman, JS; Cozier, GE; Harrison, C; Isaac, RE | 1 |
Abbulu, K; Bhende, SD; Varanasi, MB | 1 |
Berlicki, Ł; Kafarski, P; Mucha, A | 1 |
4 trial(s) available for fosinopril and fosinoprilat
Article | Year |
---|---|
Pharmacokinetics, safety, and pharmacologic effects of fosinopril sodium, an angiotensin-converting enzyme inhibitor in healthy subjects.
Topics: Adolescent; Adult; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Drug Evaluation; Fosinopril; Humans; Male; Organophosphorus Compounds; Peptidyl-Dipeptidase A; Proline; Single-Blind Method | 1991 |
The pharmacokinetics and pharmacodynamics of fosinopril in haemodialysis patients.
Topics: Administration, Oral; Adult; Biological Availability; Biotransformation; Feces; Female; Fosinopril; Humans; Hypertension; Male; Middle Aged; Renal Dialysis | 1993 |
Fosinopril: pharmacokinetics and pharmacodynamics in congestive heart failure.
Topics: Administration, Oral; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Biological Availability; Cross-Over Studies; Female; Fosinopril; Heart Failure; Humans; Injections, Intravenous; Male; Matched-Pair Analysis; Middle Aged; Prodrugs | 1995 |
Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Enalaprilat; Female; Fosinopril; Heart Failure; Humans; Kidney Failure, Chronic; Lisinopril; Male; Middle Aged; Peptidyl-Dipeptidase A; Time Factors | 2000 |
24 other study(ies) available for fosinopril and fosinoprilat
Article | Year |
---|---|
Local potentiation of bradykinin-induced vasodilation by converting-enzyme inhibition in isolated coronary arteries.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Arginine; Bradykinin; Captopril; Cattle; Coronary Vessels; Dipeptides; Enalaprilat; Endothelium, Vascular; Fosinopril; Humans; In Vitro Techniques; Lisinopril; Muscle Relaxation; Muscle, Smooth, Vascular; Nitroarginine; Ramipril; Receptors, Bradykinin; Receptors, Neurotransmitter; Vasodilation; Vasodilator Agents | 1992 |
Effects of different angiotensin-converting enzyme (ACE) inhibitors on ischemic isolated rat hearts: relationship between cardiac ACE inhibition and cardioprotection.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coronary Disease; Drug Stability; Enalaprilat; Fosinopril; Heart; In Vitro Techniques; Male; Myocardium; Organophosphorus Compounds; Prodrugs; Proline; Pyrroles; Ramipril; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1991 |
Antihypertensive activity during inhibition of neutral endopeptidase and angiotensin converting enzyme.
Topics: Amino Acids; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Fosinopril; Hypertension; Male; Neprilysin; Organophosphorus Compounds; Proline; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Sulfhydryl Compounds | 1991 |
The effect of fosinopril sodium on cerebral blood flow in moderate essential hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Blood Pressure; Cerebrovascular Circulation; Chlorthalidone; Female; Fosinopril; Humans; Hypertension; Lower Body Negative Pressure; Male; Middle Aged; Organophosphorus Compounds; Proline; Rest; Tomography, Emission-Computed, Single-Photon | 1990 |
A radioimmunoassay for SQ 27,519, the active phosphinic acid-carboxylic diacid of the prodrug fosinopril in human serum.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biological Availability; Blood Proteins; Carbon Radioisotopes; Chromatography, Thin Layer; Cross Reactions; Fosinopril; Humans; Injections, Intravenous; Organophosphorus Compounds; Prodrugs; Proline; Protein Binding; Rabbits; Radioimmunoassay | 1990 |
Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacology.
Topics: Acute Kidney Injury; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bradykinin; Captopril; Dogs; Fosinopril; Heart Rate; Injections, Intravenous; Macaca fascicularis; Male; Organophosphorus Compounds; Proline; Rats; Rats, Inbred Strains; Sympathetic Nervous System; Time Factors | 1989 |
The future of angiotensin-converting enzyme inhibitors.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Binding Sites; Captopril; Diuretics; Fosinopril; Humans; Intestinal Absorption; Kinetics; Organophosphorus Compounds; Renin; Snake Venoms; Zinc | 1985 |
Determination of SQ 27,519, the active phosphinic acid-carboxylic acid of the prodrug SQ 28,555, in human serum by capillary gas chromatography with nitrogen-phosphorus detection after a two-step derivatization.
Topics: Chemical Phenomena; Chemistry; Chromatography, Gas; Fosinopril; Humans; Hydrolysis; Indicators and Reagents; Mass Spectrometry; Proline | 1985 |
Radioenzymatic assay of angiotensin-converting enzyme inhibitors in plasma and urine.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biological Availability; Dogs; Enalapril; Enalaprilat; Fosinopril; Haplorhini; Hydrolysis; Male; Proline; Rats | 1985 |
Effects of metalloproteinase inhibitors on leukotriene A4 hydrolase in human airway epithelial cells.
Topics: Aminopeptidases; Captopril; Cell Line; Cell-Free System; Epithelium; Epoxide Hydrolases; Fosinopril; Humans; Kinetics; Leucine; Leukotriene B4; Metalloendopeptidases; Neutrophils; Protease Inhibitors | 1995 |
Single-dose and steady-state pharmacokinetics of fosinopril and fosinoprilat in patients with hepatic impairment.
Topics: Antihypertensive Agents; Creatinine; Female; Fosinopril; Humans; Liver Cirrhosis, Alcoholic; Male; Metabolic Clearance Rate; Middle Aged; Prodrugs | 1995 |
Fosinoprilate prolongs the action potential: reduction of iK and enhancement of the L-type calcium current in guinea pig ventricular myocytes.
Topics: Action Potentials; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Arrhythmia Agents; Calcium-Transporting ATPases; Cells, Cultured; Computer Simulation; Fosinopril; Guinea Pigs; Heart Ventricles; Ion Pumps; Male; Models, Cardiovascular; Sodium-Potassium-Exchanging ATPase | 1994 |
Pharmacokinetics of fosinoprilat in Chinese and whites after intravenous administration.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Asian People; China; Fosinopril; Humans; Infusions, Intravenous; Male; Metabolic Clearance Rate; White People | 1997 |
Liquid chromatographic-electrospray tandem mass spectrometric method for the simultaneous quantitation of the prodrug fosinopril and the active drug fosinoprilat in human serum.
Topics: Angiotensin-Converting Enzyme Inhibitors; Chromatography, Liquid; Fosinopril; Humans; Mass Spectrometry; Prodrugs; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Liquid chromatography/electrospray tandem mass spectrometry method for the quantitation of fosinoprilat in human serum using automated 96-well solid-phase extraction for sample preparation.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Chromatography, Liquid; Fosinopril; Humans; Hydrolysis; Mass Spectrometry; Quality Control; Reference Standards; Reproducibility of Results; Sensitivity and Specificity | 2000 |
Endogenous natriuretic peptides participate in renal and humoral actions of acute vasopeptidase inhibition in experimental mild heart failure.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cyclic GMP; Dogs; Fosinopril; Glomerular Filtration Rate; Heart Failure; Male; Neprilysin; Polysaccharides; Protease Inhibitors; Pyridines; Receptors, Atrial Natriuretic Factor; Sodium; Thiazepines | 2001 |
Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relationship, Drug; Fosinopril; Heart Conduction System; Heart Ventricles; In Vitro Techniques; Male; Myocardium; Neurons; Norepinephrine; Rats; Rats, Inbred SHR; Time Factors | 2001 |
Development of liquid chromatographic method for fosinoprilat determination in human plasma using microemulsion as eluent.
Topics: Angiotensin-Converting Enzyme Inhibitors; Calibration; Chromatography, High Pressure Liquid; Emulsions; Fosinopril; Humans; Renal Dialysis; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2005 |
Microemulsion liquid chromatographic method for characterisation of fosinopril sodium and fosinoprilat separation with chemometrical support.
Topics: Chromatography, High Pressure Liquid; Emulsions; Fosinopril; Reproducibility of Results; Sensitivity and Specificity | 2005 |
Simultaneous quantification of fosinopril and its active metabolite fosinoprilat in rat plasma by UFLC-MS/MS: Application of formic acid in the stabilization of an ester-containing drug.
Topics: Animals; Chromatography, High Pressure Liquid; Drug Stability; Formates; Fosinopril; Linear Models; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2015 |
The toxicity of angiotensin converting enzyme inhibitors to larvae of the disease vectors Aedes aegypti and Anopheles gambiae.
Topics: Aedes; Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Captopril; Disease Vectors; Fosinopril; Humans; Insecticide Resistance; Insecticides; Larva; Mosquito Vectors; Peptidyl-Dipeptidase A | 2017 |
Crystal structures of angiotensin-converting enzyme from Anopheles gambiae in its native form and with a bound inhibitor.
Topics: Aedes; Angiotensin-Converting Enzyme Inhibitors; Animals; Anopheles; Drosophila melanogaster; Fosinopril; Humans; Insect Proteins; Insecticides; Larva; Models, Molecular; Peptidyl-Dipeptidase A | 2019 |
A sensitive and efficient LC-MS/MS method for the bioanalysis of fosinopril diacid from human plasma and its application for a bioequivalence study in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Chromatography, High Pressure Liquid; Fosinopril; Humans; Male; Reference Standards; Tandem Mass Spectrometry; Therapeutic Equivalency | 2021 |
Remarkable potential of the α-aminophosphonate/phosphinate structural motif in medicinal chemistry.
Topics: Amino Acid Motifs; Chemistry, Pharmaceutical; Humans; Organophosphonates; Phosphinic Acids | 2011 |